FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

19623611000001108: Olanzapine 5mg orodispersible tablets (Teva UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 16-Nov 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
66339201000001115 Olanzapine 5mg orodispersible tablets (Teva UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
66339301000001112 Olanzapine 5mg orodispersible tablets (Teva UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Olanzapine 5mg orodispersible tablets (Teva UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Olanzapine 5mg orodispersible tablets (Teva UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Olanzapine 5mg orodispersible tablets (Teva UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Olanzapine 5mg orodispersible tablets (Teva UK Ltd) Is a Olanzapine 5mg orodispersible tablets true Inferred relationship Existential restriction modifier
Olanzapine 5mg orodispersible tablets (Teva UK Ltd) Has active ingredient Olanzapine true Inferred relationship Existential restriction modifier
Olanzapine 5mg orodispersible tablets (Teva UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Olanzapine 5mg orodispersible tablets (Teva UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Olanzapine 5mg orodispersible tablets (Teva UK Ltd) Has specific active ingredient Olanzapine true Inferred relationship Existential restriction modifier
Olanzapine 5mg orodispersible tablets (Teva UK Ltd) Has dispensed dose form Conventional release orodispersible tablet true Inferred relationship Existential restriction modifier
Olanzapine 5mg orodispersible tablets (Teva UK Ltd) Has excipient Tartrazine stain false Inferred relationship Existential restriction modifier
Olanzapine 5mg orodispersible tablets (Teva UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Olanzapine 5mg orodispersible tablets (Teva UK Ltd) Has manufactured dose form Conventional release orodispersible tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Olanzapine 5mg orodispersible tablets (Teva UK Ltd) 28 tablet 4 x 7 tablets Has AMP True Olanzapine 5mg orodispersible tablets (Teva UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start